Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory

We came across a bullish thesis on Sarepta Therapeutics, Inc. (SRPT) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on SRPT. Sarepta Therapeutics, Inc. (SRPT)'s share was trading at $118 as of Jan 17^th. SRPT’s trailing and forward P/E were 76.62 and 9.55 respectively according to Yahoo Finance.

[caption id="attachment_1223320" align="aligncenter" width="768"] A doctor examining a patient suffering from Duchenne Muscular Dystrophy, taking notes on the efficacy of the company's PMO EDO peptide.[/caption]

Sarepta...